Á. Medina-Pérez

Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?

M. Redondo, M. Casanova, E. Pérez-Ruiz, 2012, BMC Cancer.

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma

M. Moreno-Beltrán, M. Casanova, A. Rueda, 2011, Therapeutics and clinical risk management.

Pralatrexate, a new hope for aggressive T-cell lymphomas?

M. Casanova, A. Rueda, C. Quero, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?

M. Redondo, M. Casanova, E. Pérez-Ruiz, 2012, BMC Cancer.

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma

M. Moreno-Beltrán, A. Rueda, Á. Medina-Pérez, 2011 .

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma

M. Moreno-Beltrán, Á. Medina-Pérez, M. Mata-Vázquez, 2011 .